Apatinib combined with docetaxel in second-line treatment of advanced gastric cancer: A prospective clinical study (data updated)

被引：1
|
作者：
Yang, M. [1 ]
Gao, J. [1 ]
Liu, X. [1 ]
Lu, H. [1 ]
机构：
[1] Shanxi Canc Hosp, Digest Dept Oncol, Taiyuan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1934
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1428P
引用
收藏
页码：S903 / S903
页数：1
相关论文
共 50 条
  • [1] Apatinib combined with docetaxel in second-line treatment of advanced gastric cancer: A prospective clinical study (data updated)
    Yang, M.
    Gao, J.
    Liu, X.
    Xu, Z.
    Lu, H.
    Yang, W.
    Li, H.
    Li, Y.
    ANNALS OF ONCOLOGY, 2019, 30
  • [2] Apatinib combined with docetaxel in second-line treatment of advanced gastric cancer: A prospective randomized controlled clinical study
    Wang, Z.
    Dai, G.
    Zhou, Y.
    Hui, H.
    Zhang, P.
    Gou, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [3] Clinical efficacy and safety of apatinib combined with docetaxel in second-line treatment for advanced gastric cancer: A prospective study.
    Yang, Mudan
    Gao, Jun
    Xu, Zhou
    Lu, Hongxia
    Yang, Wenhui
    Li, Li
    Li, Hui
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] EFFICACY ANALYSIS OF APATINIB COMBINED WITH CHEMOTHERAPY IN THE TREATMENT OF ADVANCED SECOND-LINE GASTRIC CANCER
    Fan, Cuizhen
    Guo, Hongqiang
    Chu, Yuping
    An, Guangyu
    ACTA MEDICA MEDITERRANEA, 2022, 38 (01): : 1 - 5
  • [5] Efficacy and safety of intermittent versus continuous dosing schedule of apatinib combined with docetaxel as second-line treatment for advanced gastric cancer.
    He, Yifu
    Yan, Ying
    Wang, Gang
    Sun, Yubei
    Xu, Tengyun
    Wu, Shusheng
    Luo, Huiqin
    Ke, Lihong
    Hu, Xiaoxiu
    Niu, Jiayu
    Li, Huimin
    Chen, Wenju
    Xu, Huijun
    Cao, Lulu
    Sun, Yancai
    Liu, Chenxuan
    Ji, Chushu
    Hu, Bing
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [6] Apatinib combined with S-1 as second-line therapy in advanced gastric cancer
    Qiu, Zhi-Yuan
    Qin, Rong
    Tian, Guang-Yu
    Zhang, Zhao
    Chen, Meifang
    He, Han
    Xi, Yan
    Wang, Yan
    MEDICINE, 2021, 100 (17) : E25630
  • [7] A clinical study of docetaxel with or without 5'DFUR as a second-line chemotherapy for advanced gastric cancer
    Maruta, Fukuto
    Ishizone, Satoshi
    Hiraguri, Manabu
    Fujimori, Yoshiro
    Shimizu, Fumiaki
    Kumeda, Shigeyoshi
    Miyagawa, Shinichi
    MEDICAL ONCOLOGY, 2007, 24 (01) : 71 - 75
  • [8] Docetaxel and oxaliplatin combination in second-line treatment of patients with advanced gastric cancer
    Carlo Barone
    Michele Basso
    Giovanni Schinzari
    Carmelo Pozzo
    Nunziatina Trigila
    Ettore D'Argento
    Michela Quirino
    Antonio Astone
    Alessandra Cassano
    Gastric Cancer, 2007, 10 : 104 - 111
  • [9] DOCETAXEL-GEMCITABINE AS SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED GASTRIC CANCER
    D'Alessio, Andrea
    Amato, Maria Grazia
    Resta, Davide
    Sbarufatti, Antonio
    Tacchini, Laura
    Venturi, Cristina
    Visacarra, Cecilia
    ANNALS OF ONCOLOGY, 2009, 20
  • [10] A clinical study of docetaxel with or without 5′DFUR as a second-line chemotherapy for advanced gastric cancer
    Fukuto Maruta
    Satoshi Ishizone
    Manabu Hiraguri
    Yoshiro Fujimori
    Fumiaki Shimizu
    Shigeyoshi Kumeda
    Shinichi Miyagawa
    Medical Oncology, 2007, 24 : 71 - 75
12345